
Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc. (MIST)
WebsitePrice
Market cap
Next catalystExpected 2H 2028CARDAMYST (etripamil) — AFib-RVR · Phase 3 dataCompany release ↗
Cash
Chart & Events
Core Clinical
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
Other pipelines
MIST PR & News
PR & News
Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc.